Toshihisa Nakashima

8PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular medicinePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 29, 2026
Effectiveness of continuous pharmacist intervention at maintaining dose intensity in postoperative adjuvant S-1 chemotherapy for gastric cancer: a multicentre retrospective study.

|May 29, 2026
Current pharmacological and non-pharmacological approaches to chemotherapy-induced peripheral neuropathy and association with awareness of clinical guidelines.

|Feb 19, 2026
Clinical Determinants of Early Achievement of the Therapeutic Teicoplanin Trough Concentration Range in Adult Cancer Patients.

Toshihisa Nakashima, Osamu Kobayashi, Mika Shiotsuka

|Jun 10, 2025
The optimal conversion ratio of tacrolimus switching from intravenous to oral tacrolimus administration in hematopoietic cell transplantation patients receiving posaconazole prophylaxis with and without letermovir.

Toshihisa Nakashima, Azusa Kawasaki, Yoshihiro Inamoto

|Feb 10, 2025
Concomitant letermovir affects the optimal concentration-to-dose ratio of tacrolimus after switching from intravenous to oral tacrolimus administration in hematopoietic cell transplantation patients receiving fluconazole prophylaxis.

Toshihisa Nakashima, Yoshihiro Inamoto, Ayumu Ito

|Mar 07, 2021
Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation.

Toshihisa Nakashima, Yoshihiro Inamoto, Yayoi Fukushi

Pageof 2

Frequent Collaborators

2 joint publications

Yoshihiro Inamoto

1 joint publications

Sena Yamamoto

1 joint publications

Harue Arao

1 joint publications

Yoichiro Yoshida